Navigation Links
Positive Phase 1 Clinical Trial Results for Transdermal Lidocaine
Date:12/8/2008

Trial Demonstrates Increased Dermal Penetration of TPM/Lidocaine Compared to Topical Anaesthetic Xylocaine(R)

MELBOURNE, Australia, Dec. 8 /PRNewswire-FirstCall/ --Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of a phase 1 clinical trial that examined the ability of its patented drug delivery system, TPM, to topically deliver the pain relief drug, lidocaine, safely into humans. The trial demonstrated that the patented lidocaine formulation was able to deliver a significantly greater amount of lidocaine into the localised area of the skin compared to a leading commercial product.

Lidocaine is a well known topical anaesthetic, sales of which exceeded US $1.2 billion in 2007. It is used for a wide variety of ailments, including temporary relief of rashes, stings, sprains, strains, bites, and burns. This clinical trial compared the dermal penetration and measured the systemic exposure of lidocaine between one of the leading marketed products, Xylocaine(R) (5% lidocaine), and Phosphagenics' TPM/lidocaine (5% lidocaine).

One hour after application, TPM/lidocaine delivered 500 percent more (p<0.001) lidocaine into the stratum corneum, the outer layer of the skin, than the commercial product, Xylocaine(R). Phosphagenics' TPM/lidocaine also augmented the depth of penetration, with 450 percent (p<0.01) more lidocaine found in the deepest layers of the skin sampled.

TPM/lidocaine significantly increased the amount, rate, and depth of lidocaine penetration into the skin compared to Xylocaine(R), parameters that are normally expected to produce a local analgesic effect. Despite the increase in dermal drug delivery, TPM/lidocaine did not increase the plasma lidocaine concentration compared to Xylocaine(R) after 6 hours.

Dr. Esra Ogru, Executive Vice President of Research and Development
'/>"/>

SOURCE Phosphagenics Limited
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin
2. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
3. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
4. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
5. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
6. Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
7. Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
8. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
9. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
10. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
11. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 21, 2015  CryoLife, Inc. (NYSE: CRY ), ... on cardiac and vascular surgery, announced today that its ... for the second quarter 2015 of $0.03 per share ... $0.03 per share will be paid on June 19, ... June 12, 2015.  The ex-dividend date for the quarterly ...
(Date:5/21/2015)... Mass. , May 21, 2015  (MUSE ... the Electronic Health Record (EHR) is invaluable in ... Though EHRs are now a requirement and mainstream ... and continuously into the EHR is gaining traction ... Exchange), William Holmes, RN, Site Project Manager & ...
(Date:5/21/2015)... 21. Mai 2015 Dipexium ... ein Unternehmen für Arzneimittel im fortgeschrittenen ... und Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) ... eine wissenschaftliche Posterpräsentation an, welche das ... vorstellt, OneStep-1 und OneStep-2, in der ...
Breaking Medicine Technology:CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... 2011 Talyst announces AutoPharm® Mobile, an Apple ... mobile application can be conveniently accessed on an ... and control across the health system. ... have real-time access to medication inventory throughout the ...
... Reportlinker.com announces that a new market research ... Global Medical Laser Systems Industry ... This report analyzes the worldwide markets ... by the following Product Segments: Surgical Lasers, ...
Cached Medicine Technology:Talyst Releases AutoPharm Mobile 2Global Medical Laser Systems Industry 2
(Date:5/22/2015)... (PRWEB) May 22, 2015 Hands On ... June 17, 2015, the Annual One Day Sale ... 2007, Hands On HCMT offers drastically reduced certificates one day ... estheticians have enough sessions, through what used to be the ... wonderful for the community as well. This once a year ...
(Date:5/22/2015)... Memorial Day weekend is typically considered the ... offering some tips to help promote safe travel. , According ... 383 traffic fatalities this Memorial Day weekend. Amica is sharing ... Safety Association: , , Always wear ... a seatbelt, whether they’re driving or riding along as a ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 According to ... hub for drug related death, totaling almost 2,500 confirmed drug ... reported by state officials, totals 2,489 deaths stemming from legal ... out, Pennsylvania loses seven people every day to fatal overdoses ... been singled out as one of the most rife with ...
(Date:5/22/2015)... A Phase 3 French study, ... of Clinical Oncology (ASCO)’s annual meeting at the ... those patients who received bevacizumab in addition to ... (Avastin® Genentech, Inc.) is an antibody that blocks ... routinely used to treat many other cancers, including ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President and ... by Consulting-Specifying Engineer (CSE) magazine as a young leader ... the May/June issue of the publication. , This award ... and younger who have, and continue to make significant ... other areas of their professional and personal endeavors. Candidates ...
Breaking Medicine News(10 mins):Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 2Health News:Hands On HealthCare Massage Therapy & Wellness Day Spa Announces Their Eighth Annual One Day Sale on Gift Certificates Will Take Place on June 17, 2015 3Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2
... HealthDay Reporter , THURSDAY, Dec. 16 (HealthDay ... approval of the drug Avastin to fight breast cancer, ... its potential for serious side effects. But the ... officials at a news conference, will not immediately affect ...
... , , , , , ... AUDIO: People with a known risk for Alzheimers disease ... Click here for more information. , , ... , , , , , ...
... , THURSDAY, Dec. 16 (HealthDay News) -- A new study ... overqualified workers can bring to their companies. "If anything, ... to stay longer and perform better than an applicant whose ... assistant professor of management at the University of South Carolina, ...
... from Italy determined that radiofrequency ablation (RFA) is a ... in cirrhotic patients. The high repeatability of RFA is ... liver. Results of this 10-year retrospective study are available ... a journal published by Wiley-Blackwell on behalf of the ...
... WASHINGTON The American College of Physicians (ACP) today made a ... available free for ordering and distribution. Consumer Guide to ... English and Spanish and organized in a way that clearly ... made and when the changes will take effect. It ...
... The World Health Organization set a target for the influenza ... elderly population and an increase to more than 75% by ... the old German states. In the current issue of ... 107[48]: 845󈞞) the working group around Annicka M. Reuss presents ...
Cached Medicine News:Health News:FDA Advises Against Avastin as Treatment for Breast Cancer 2Health News:FDA Advises Against Avastin as Treatment for Breast Cancer 3Health News:MRI scans reveal brain changes in people at genetic risk for Alzheimer's 2Health News:MRI scans reveal brain changes in people at genetic risk for Alzheimer's 3Health News:MRI scans reveal brain changes in people at genetic risk for Alzheimer's 4Health News:MRI scans reveal brain changes in people at genetic risk for Alzheimer's 5Health News:Overqualified Workers May Be Less Likely to Quit Jobs 2Health News:Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation 2
... sized High-Throughput Submarine Systems are designed ... from microtitre plates. Analyze high numbers ... oligos or PCR products simultaneously. The ... accuracy and speed with additional savings ...
... Dodeca cell runs up to 12 mini ... minutes. Handcast gels can be poured 12 ... 485 gradient former and Mini-PROTEAN 3 multi-casting ... reproducibility. Alternatively, Ready Gel precast gels offer ...
... Criterion Dodeca cell, a component of the Criterion ... to 12 Criterion gels in a single run. ... 8.7 cm) than the traditional mini gel. They ... give you the optimal combination of separation and ...
... runs up to 12 mini gels under ... gels can be poured 12 at a ... former and Mini-PROTEAN 3 multi-casting chamber, eliminating ... Ready Gel precast gels offer the convenience ...
Medicine Products: